Physician profile
Jacob Vincent
NPI 1649730805
$6,038.70
in general payments reported to CMS, 2019-2025
11 companies · $4,296 in 2025
The $4,296 reported for 2025 was more than what 81% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $258 · 2023: $715 · 2024: $769 · 2025: $4,296.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,017 · Travel and Lodging: $2,662 · Education: $102.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,017.35 |
| Travel and Lodging | $2,661.98 |
| Education | $101.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $1,827.58 | 2024-2025 | Aetos Shoulder System, Evos, Maverick |
| Stryker Corporation | $1,288.50 | 2022-2025 | Pro, T2 Alpha, Gamma |
| Synthes Gmbh | $1,170.68 | 2025 | |
| Zimmer Biomet Holdings, INC. | $1,109.79 | 2023-2025 | Persona, Rosa, Affixus |
| Depuy Synthes Sales INC. | $170.23 | 2024-2025 | Tfn-Advance, Lcp |
| Cdc Medical LLC | $149.74 | 2023-2024 | |
| Curvafix, INC. | $106.06 | 2022 | |
| Medical Device Business Services, INC. | $71.78 | 2025 | Na |
| Arthrex, INC. | $65.07 | 2024 | Extremities & Trauma Implants Long Bone Trauma Femoral Fracture |
| Kyocera Medical Technologies, INC. | $63.18 | 2022 | |
| Bioventus LLC | $16.09 | 2025 | Exogen Ultrasound Bone Healing System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jacob Vincent listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.